Home » Topics » BioWorld Science

BioWorld Science
RSS

Atreca announces agreement with Zymeworks and selection of new clinical candidate

April 6, 2022

PEAR1 genetic variation tied to big endothelin levels in patients with acute myocardial infarction

April 6, 2022

New SPNS2 inhibitors synthesized by University of Virginia

April 6, 2022

Schroedinger identifies new CDC7 inhibitors

April 6, 2022

Gasherbrum Bio presents new GLP-1 receptor agonists

April 6, 2022

New HBV antiviral compounds patented by Janssen

April 6, 2022

Shaanxi Micot Technology discloses new CaSR agonists

April 6, 2022

OPG is an independent factor for coronary artery calcification in hypertension

April 6, 2022

Elevated troponin in patients with COVID-19 is an independent risk factor for mortality

April 6, 2022

NUAK1 inhibition as new antifibrotic treatment strategy

April 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...